The Essex Cardiothoracic Centre (CTC) is establishing itself as one of the foremost centres for cardiac care and research in the UK.
Cardiologists and researchers based at the CTC have presented their research findings at world-renowned conferences over the summer, with some winning prestigious awards.
As well as presenting at the British Cardiac Intervention Society (BCIS) in January, Dr Shah Modhnazri, doctoral student at Anglia Ruskin University (ARU) was nominated as young investigator of the year, in May, at the EuroPCR in Paris, for his work on the IMPACT CTO study.
The study was developed at the CTC to research the impact of having a stent inserted into a blocked artery, and the overall effect on the other two heart arteries. All patients taking part in the study had pre-existing heart disease and had all three of their arteries measured before, during and four months after surgery. In each case a stent was inserted into the blocked artery and the measurements taken during the study looked at the impact the repair has on the other two (unblocked) arteries.
The Essex CTC is now regarded as one of the leading UK centres for cardiac arrest care. Two of the eight presentations at the Lund Cardiac Arrest Symposium in Sweden in September 2017, were given by CTC researchers.
Dr Thomas Keeble, consultant cardiologist and senior research fellow, said: “The CTC is now accepted both on a UK and European platform as offering truly cutting edge care and research.”
The recent accolades have led the British Cardiac Society (BCS) to ask the CTC to organise the first ever BCS study day on the subject of “out of hospital cardiac arrest”, to be held at the Royal Society of Medicine on 27 November 2017.
Dr Keeble added: “This is the jewel in the crown for us – to be accepted as a UK leader in cardiology. The course is aimed at consultant cardiologists and looks at the management of out-of-hospital cardiac arrests, from field to follow-up. We’re honored to have won the right to host this prestigious meeting.”